Sandoz AG - Company & Market Research Reports

Sandoz is recognized as the global leader in biosimilars and generic antibiotics, dermatology and transplantation medicines. It also holds leading global positions in areas ranging from generic cardiovascular, central nervous system (CNS), pain and ophthalmology to oncology, respiratory and hormonal therapeutics. Its products are sold in more than 160 countries, and reach more than 500 million patients. The company was founded in 1946 and is based in Princeton, New Jersey.

Humira Biosimilars Clinical Trial Insight - Product Thumbnail Image

Humira Biosimilars Clinical Trial Insight

  • Clinical Trials
  • 80 Pages
From
From
From
From
From
From
From
PDE Inhibitors Market, 2016-2026 - Product Thumbnail Image

PDE Inhibitors Market, 2016-2026

  • Report
  • 223 Pages
From
From
From
From
Loading Indicator
adroll